MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
MS Virtual 2020

MS Virtual 2020: Looking Forward to the Week Ahead

MStranslate
September 8, 2020
Conferences, MS Virtual, Research
1 Comment
The world’s largest multiple sclerosis conference begins this week.  ECTRIMS (the European Committee for Treatment and Research In Multiple Sclerosis) brings together researchers and clinicians from around...
Anacardic Acid

Anacardic Acid: Potential Myelin Repair Therapy

MStranslate
August 25, 2020
Remyelination, Research
3 Comments
Remyelination is the next ‘big thing’ in the treatment and management of multiple sclerosis.  The ability to repair damaged myelin in people living with multiple sclerosis has the potential to not only...
calorie restriction

Calorie Restriction Promotes Myelin Repair

MStranslate
August 5, 2020
Diet, Lifestyle, Remyelination, Research
Research Summary: Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis Remyelination or myelin repair is the current ‘holy grail’ of multiple...
millennium

MS Research in the New Millennium: 2000 – 2020

MStranslate
July 23, 2020
Research, Treatments
It’s been 20 years since the world nervously welcomed the new millennium.  Let’s look back on those two decades and examine the major developments in Multiple Sclerosis research and treatment. Twenty...
bile acids

Bile Acids May Play Role in Multiple Sclerosis

MStranslate
June 23, 2020
Research, Treatments
2 Comments
Research Summary: Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation A joint investigation undertaken by researchers at Johns Hopkins University, the...
Facebook Live

Facebook Live: General Research Update – June 2020

MStranslate
June 9, 2020
Community, Q&A, Research
On June 4, 2020, our co-founder and chief science communicator, Brett Drummond, held a Facebook Live event to explain and discuss some of the more recent developments in multiple sclerosis research. Topics...
epstein-barr virus

Epstein-Barr Virus & MS: New Study Outcomes

MStranslate
May 20, 2020
Epstein-Barr virus, Infection, Research, Videos
1 Comment
Research Summary: Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis A German study involving 901 people living with early multiple sclerosis (MS) has found...
Ursolic acid

Fruit Peel Compound Shows Treatment Potential

MStranslate
April 7, 2020
Research, Treatments
Research Summary:  A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination A newly published study in the highly respected medical journal,...
AHSCT

BEAT-MS Trial to Compare AHSCT to MS Treatments

MStranslate
January 14, 2020
Research, Stem Cells, Treatments
Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS).  As well as this, we have recently seen a number...
Facebook Live

Facebook Live: Research Update – December 2019

MStranslate
December 5, 2019
Community, Q&A, Research
On December 4, 2019, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss a number of recent important developments in multiple sclerosis...
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.